ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
Miller, R.E., Leary, A., Scott, C.L., Serra, V., Lord, C.J., Bowtell, D., Chang, D.K., Garsed, D.W., Jonkers, J., Ledermann, J.A., Nik-Zainal, S., Ray-Coquard, I., Shah, S.P., Matias-Guiu, X., Swisher, E.M., Yates, L.R.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival
Zwimpfer, T.A., Pandey, A., Fereday, S., Coelho, R.J.B-N., Twomey, L., Ariyaratne, D., Traficante, N., Jacob, F., Eller, R., Heinzelmann-Schwarz, V., Christie, E.L., Kennedy, C., Au-Yeung, G., Ramus, S., Koebel, M., Nelson, B., Goode, E.L., DeFazio, A., Bowtell, D.D.L., Garsed, D.W.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
8P Biomarkers to predict chemotherapy response in low-grade serous ovarian carcinoma
Kumari, S., Moujaber, T., Gloss, B., Madsen, I., Gao, B., Provan, P., Srirangan, S., Bouantoun, N., Kennedy, C., Traficante, N., Friedlander, M.L., Brand, A., Gourley, C., Garsed, D.W., Bowtell, D., Harnett, P., Balleine, R., Defazio, A.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article
16P Response to taxanes in low-grade serous ovarian cancer patients and cell lines
Kumari, S., Moujaber, T., Madsen, I., Gao, B., Provan, P., Srirangan, S., Bouantoun, N., Kennedy, C., Sharma, R., Fereday, S., Traficante, N., Friedlander, M.L., Brand, A., Gourley, C., Garsed, D.W., Bowtell, D., Balleine, R., Harnett, P., DeFazio, A.
Published in ESMO open (01.03.2023)
Published in ESMO open (01.03.2023)
Get full text
Journal Article